Qualcomm and Arm Head Back to Court, Dispute Centers on Massive Damages
nashnova research
Qualcomm and Arm returned to a Delaware federal court on October 6, 2026, for a five-day jury trial over contract breach and potentially billions of dollars in royalty payments. The outcome will directly shape Qualcomm's bargaining position when its license agreement with Arm comes up for renewal before 2033.
What exactly is Qualcomm suing over?
Qualcomm accuses Arm of two things: refusing to provide contractually required chip-testing tools, and leaking to the media that it threatened to terminate a key license agreement in 2024.
Qualcomm says the leak damaged its chip-deal negotiations with Meta Platforms.
The remedy Qualcomm seeks is specific: up to five years of royalty-free status. This means → if Qualcomm wins, Arm stands to lose billions of dollars in revenue.
How is Arm pushing back?
Arm denies any breach and argues the chip-deal losses Qualcomm claims are speculative damages with no legal standing.
Arm fires back with its own charge: Qualcomm itself leaked non-public details of an antitrust probe that Arm was facing. This means → Arm contends Qualcomm has no standing to claim damages over leaks when it did the same thing.
Judge Maryellen Noreika is weighing whether to strike the relevant contract clause — if she does, Qualcomm's potential damages would shrink dramatically.
What is the structural conflict behind this lawsuit?
Arm, owned by Japan's SoftBank Group, has spent decades licensing foundational chip designs to companies like Qualcomm and Nvidia. In plain terms = Arm draws the blueprints; Qualcomm builds the chips.
In recent years Arm began selling its own chip products, competing directly with its own customers. This reflects a structural shift across the semiconductor supply chain — the licensor becoming a rival.
Qualcomm is one of Arm's largest customers. It dominates Android smartphone chips and has been expanding into data-center chips — widening the overlap between the two companies.
What does the verdict change?
This five-day trial is the latest round in a fight dating back to Arm's 2022 lawsuit. Qualcomm scored a key win in 2024 in related proceedings.
A separate bench trial is running in parallel: the judge will hear whether Arm negotiated in good faith over next-generation chip technology licenses.
Put simply = the damages ruling here is not just about one payment — it determines how much leverage Qualcomm carries into renewal talks before the 2033 agreement expiration.
市场有风险，内容仅供研究参考，不构成投资建议。